| 2025-11-24 | +42.7% | news | Seeking Alpha | Inspire jumps on major change to Medicare reimbursement |
| 2025-08-05 | -39.9% | earnings | Investor's Business Daily | Inspire Medical Systems Crashes 32% As Eli Lilly's GLP-1 Weighs On Guidance - Investor's Business Daily |
| 2025-08-05 | -39.9% | earnings | MassDevice | Inspire Medical stock takes a big hit on slashed guidance, next-gen launch slowdown - MassDevice |
| 2025-08-05 | -39.9% | analyst | Investing.com South Africa | Truist Securities downgrades Inspire Medical Systems stock on growth concerns By Investing.com - Investing.com South Africa |
| 2024-05-07 | -35.0% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-08-04 | -31.3% | legal | SEC EDGAR | INSP 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2024-05-08 | -29.6% | earnings | MassDevice | Inspire Medical stock sinks despite Q1 sales gain, guidance increase - MassDevice |
| 2024-08-06 | +29.2% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2023-11-07 | -21.3% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2025-12-18 | -19.7% | news | Seeking Alpha | Inspire Medical slides after Medicare reimbursement policy change |
| 2025-11-03 | +18.9% | earnings | Seeking Alpha | Inspire Medical Systems Non-GAAP EPS of $0.38 beats by $0.55, revenue of $224.5M beats by $4.11M |
| 2025-11-03 | +18.9% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-03 | +18.9% | earnings | MassDevice | Inspire stock rises after hours on Street-beating Q3 - MassDevice |
| 2025-11-03 | +18.9% | earnings | Zacks Investment Research | 3 MedTech Stocks Positioned to Surpass Q3 Earnings Estimates - Zacks Investment Research |
| 2026-01-22 | -18.0% | analyst | Seeking Alpha | Inspire downgraded at Oppenheimer following CMS NCD correction |
| 2026-01-22 | -18.0% | news | Yahoo Finance | Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Yahoo Finance |
| 2025-01-13 | -16.3% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-05-04 | -15.4% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2025-11-04 | +13.2% | earnings | Seeking Alpha | Inspire Medical Systems signals 10–11% revenue growth for 2026 while reaffirming $900M–$910M guidance for 2025 |
| 2025-11-04 | +13.2% | earnings | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Q3 2025 Earnings Call Transcript |
| 2025-11-04 | +13.2% | earnings | Seeking Alpha | Inspire Medical Systems, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-04 | +13.2% | earnings | Zacks Investment Research | INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands - Zacks Investment Research |
| 2025-11-04 | +13.2% | analyst | Investing.com | Mizuho lowers Inspire Medical Systems stock price target to $110 on modest growth outlook - Investing.com |
| 2021-08-03 | +12.6% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2024-07-29 | +11.4% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2026-02-12 | -10.9% | news | Seeking Alpha | Inspire Medical: Still A Long Way From A Good Night's Sleep |
| 2026-02-12 | -10.9% | earnings | Seeking Alpha | Inspire Medical Systems signals 2026 revenue outlook of $950M-$1B amid coding changes and reimbursement headwinds |
| 2026-02-12 | -10.9% | earnings | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript |
| 2026-02-12 | -10.9% | earnings | Seeking Alpha | Inspire Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-11 | -10.9% | earnings | Seeking Alpha | Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook |
| 2026-02-11 | -10.9% | earnings | Seeking Alpha | Inspire Medical Systems Non-GAAP EPS of $1.65 beats by $0.97, revenue of $269.1M beats by $2.88M |
| 2026-02-11 | -10.9% | legal | SEC EDGAR | INSP 8-K: 2.02, 5.03, 7.01 (SEC Filing) |
| 2025-09-03 | -10.0% | news | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript |
| 2026-02-26 | +9.9% | news | Seeking Alpha | Inspire Medical surges after KeyBanc sees CMS adding codes for Inspire V implant |
| 2024-11-12 | -9.6% | legal | SEC EDGAR | INSP 8-K: 8.01 (SEC Filing) |
| 2023-02-07 | +9.5% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2025-11-10 | +9.0% | news | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Presents at UBS Global Healthcare Conference 2025 Transcript |
| 2022-11-01 | +9.0% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2025-09-02 | -8.4% | analyst | Seeking Alpha | Inspire Hit By System Adoption Friction: A HOLD Rating Assigned |
| 2022-06-22 | +8.2% | legal | SEC EDGAR | INSP 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-05-03 | -8.0% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2024-02-06 | -7.6% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-25 | +6.9% | news | Exoswan Insights | Top Neurotech Stocks 2026 Watchlist: Slowing the Silver Tsunami - Exoswan Insights |
| 2024-01-08 | +6.8% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-05-02 | +6.8% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2025-12-02 | +6.1% | news | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript |
| 2026-01-12 | -6.0% | news | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-01-12 | -6.0% | earnings | Seeking Alpha | Inspire Medical Systems announces Q4 and FY25 guidance, appoints new CFO |
| 2026-01-12 | -6.0% | legal | SEC EDGAR | INSP 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-08-11 | +5.2% | legal | SEC EDGAR | INSP 8-K: 8.01 and (SEC Filing) |
| 2025-08-11 | +5.2% | news | MassDevice | Inspire Medical authorizes $200M share repurchase - MassDevice |
| 2024-08-02 | +5.0% | legal | SEC EDGAR | INSP 8-K: 8.01 and (SEC Filing) |
| 2024-04-05 | +4.5% | news | Seeking Alpha | Inspire Medical Systems: A Potential Example Of Market Mispricing (NYSE:INSP) - Seeking Alpha |
| 2025-10-24 | -4.5% | news | Seeking Alpha | Inspire Medical cut at Jefferies on GLP-1 uptake, potential rivalry |
| 2025-12-03 | +4.1% | news | Seeking Alpha | Inspire Medical: A Better Night Of Sleep |
| 2024-07-22 | -4.1% | legal | SEC EDGAR | INSP 8-K: 5.02 (SEC Filing) |
| 2021-07-15 | +3.8% | earnings | Zacks Investment Research | What date does Inspire Medical Systems's (INSP) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2024-02-05 | +3.7% | legal | SEC EDGAR | INSP 8-K: 5.02 and (SEC Filing) |
| 2025-02-11 | +3.6% | legal | MassDevice | Inspire Medical faces DOJ investigation - MassDevice |
| 2022-08-02 | +3.5% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2022-08-02 | +3.5% | legal | SEC EDGAR | INSP 8-K: 5.02 (SEC Filing) |
| 2024-11-04 | +3.4% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-13 | -3.3% | news | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-02-10 | +3.1% | earnings | Seeking Alpha | Inspire Medical Systems Q4 2025 Earnings Preview |
| 2022-02-08 | +3.1% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2026-03-17 | -3.1% | news | Seeking Alpha | Inspire Medical Systems, Inc. (INSP) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript |
| 2026-04-13 | +3.0% | news | StockStory | 1 of Wall Street’s Favorite Stock Worth Investigating and 2 We Brush Off |
| 2025-08-23 | -2.8% | news | Seeking Alpha | Inspire Medical: Hiccups For The Sleep Business |
| 2025-05-05 | +2.7% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-22 | -2.7% | news | Finviz | Here's Why You Should Retain INSP Stock in Your Portfolio Now - Finviz |
| 2022-08-15 | -2.7% | legal | SEC EDGAR | INSP 8-K: 8.01 and (SEC Filing) |
| 2025-11-02 | +2.1% | earnings | Seeking Alpha | Inspire Medical Systems Q3 2025 Earnings Preview |
| 2026-04-03 | -2.0% | news | Cổng thông tin điện tử Tỉnh Sơn La | SIBN Stock Analysis: SI-BONE Inc. Orthopedic Med Stock Posts Minor Daily Gain At 13.12 - Cổng thông tin điện tử Tỉnh Sơn La |
| 2023-06-12 | -1.8% | legal | Yahoo Finance | Inspire (INSP) Gets FDA Nod for Expanded Indication of AHI - Yahoo Finance |
| 2023-08-01 | -1.8% | legal | SEC EDGAR | INSP 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-04-15 | -1.7% | earnings | MT Newswires | Truist Lowers Price Target on Inspire Medical Systems to $64 From $70, Keeps Hold Rating |
| 2026-04-06 | -1.6% | news | Insider Monkey | Inspire Medical (INSP) is Gaining Strength from Its Product Offering and Differentiation |
| 2026-04-06 | -1.6% | news | GlobeNewswire | Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026 |
| 2025-12-28 | -1.5% | news | TMX Newsfile | INSP REMINDER: Inspire Medical Systems, Inc. Investors are Alerted of the Imminent January 5 Deadline and to Contact BFA Law if You Lost Money - TMX Newsfile |
| 2021-05-21 | +1.5% | legal | SEC EDGAR | INSP 8-K: 8.01 and (SEC Filing) |
| 2025-07-23 | -1.5% | earnings | MarketBeat | Adam Maeder Analyst Performance at Piper Sandler - MarketBeat |
| 2025-11-17 | -1.5% | legal | SEC EDGAR | INSP 8-K: 8.01 (SEC Filing) |
| 2025-08-26 | -1.3% | earnings | Seeking Alpha | Inspire Medical reaffirms updated 2025 guidance |
| 2025-08-26 | -1.3% | executive | Seeking Alpha | Inspire Medical Systems CFO departs |
| 2025-08-26 | -1.3% | legal | SEC EDGAR | INSP 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-08-26 | -1.3% | executive | MassDevice | Inspire Medical CFO departs to pursue other opportunities - MassDevice |
| 2025-07-25 | +1.2% | earnings | MarketBeat | Daniel Markowitz Analyst Performance at Evercore - MarketBeat |
| 2023-12-27 | +1.2% | news | MassDevice | Investors file class action against Inspire Medical, allege misleading statements - MassDevice |
| 2025-10-14 | +1.2% | earnings | Yahoo Finance | Here’s What Happened to Inspire Medical (INSP) in Q3 - Yahoo Finance |
| 2026-04-14 | +1.1% | earnings | Zacks | Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names |
| 2026-04-14 | +1.1% | earnings | MT Newswires | RBC Cuts Price Target on Inspire Medical Systems to $56 From $68, Keeps Sector Perform Rating |
| 2025-11-07 | +1.0% | expansion | MassDevice | Inspire Medical faces investor class action over Inspire V launch allegations - MassDevice |
| 2026-04-08 | +1.0% | news | Zacks | Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now |
| 2026-04-08 | +1.0% | news | StockStory | 1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off |
| 2026-04-08 | +1.0% | news | Zacks Investment Research | Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now - Zacks Investment Research |
| 2024-01-26 | +1.0% | legal | SEC EDGAR | INSP 8-K: 5.02 and (SEC Filing) |
| 2025-05-06 | -1.0% | expansion | MassDevice | Inspire Medical to fully launch next-gen system in U.S. this month - MassDevice |
| 2025-07-16 | -1.0% | earnings | MarketBeat | Kallum Titchmarsh Analyst Performance at Morgan Stanley - MarketBeat |
| 2026-04-09 | +0.7% | news | Zacks | Here's Why You Should Retain Clover Stock in Your Portfolio for Now |
| 2024-12-04 | -0.6% | news | Yahoo Finance | 5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025 - Yahoo Finance |
| 2026-03-11 | -0.4% | news | Seeking Alpha | Inspire Medical: Sleeping Giant Awakens The OSA Implant Market, Initiating With A Buy |
| 2021-11-02 | +0.3% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2025-02-10 | +0.3% | legal | SEC EDGAR | INSP 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-12-28 | +0.2% | legal | SEC EDGAR | INSP 8-K: 5.02 and (SEC Filing) |
| 2026-03-05 | -0.2% | news | TradingView | Here's Why You Should Retain INSP Stock in Your Portfolio for Now - TradingView |
| 2023-01-09 | +0.1% | legal | SEC EDGAR | INSP 8-K: 2.02 and (SEC Filing) |
| 2026-04-24 | — | earnings | Insider Monkey | Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1 |